Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]

Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis

Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis

In a lawsuit filed by the state of Oklahoma against Johnson & Johnson, Inc., Purdue Pharma LP and Teva Pharmaceutical Industries Ltd., the pharmaceutical giant Johnson & Johnson and its subsidiaries were ordered on Aug. 26, 2019 to pay $572 million in penalties for helping to fuel the opioid crisis in Oklahoma.1 Before the trial […]

NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans

NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans

Story Highlights NIH, in collaboration with Johnson & Johnson, will begin HIV vaccine efficacy trials on humans in August 2019 in the U.S. Another HIV vaccine candidate, using a live attenuated herpes cytomegalovirus (CMV), is also nearing clinical trials in humans. There are serious safety concerns regarding live attenuated vaccines and numerous cases reported in […]